Mylan partners to make Botox biosimilar

06-03-2018

Mylan partners to make Botox biosimilar

Mylan has revealed plans to develop and commercialise a proposed biosimilar to Botox (onabotulinumtoxinA).


Mylan, biosimilar, Revance Therapeutics, Botox, Allergan, collaboration, licence, pipeline, neuromodulator

LSIPR